SSKN earnings

HORSHAM, Penn., Nov. 05, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report third quarter 2025 financial results on Thursday, November 13, 2025 after the market close. STRATA management will subsequently host a conference call at 4:30 p.m. ET on Thursday, November 13, 2025 to review financial results and provide an update on corporate developments. Following management's formal remarks, there will be a question-and-answer session. To listen to the conference call, in

HORSHAM, Penn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended June 30, 2025, and provides a corporate update. Second Quarter Highlights Historic expansion of CPT codes for reimbursement for inflammatory and auto-immune skin diseases, effectively tripling the covered patient population in the USPotential acceleration of expanded reimbursement coverage through application for G-codes to gain access by 2026 cycleSubmission of econom

HORSHAM, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report second quarter 2025 financial results on Wednesday, August 13, 2025 after the market close. STRATA management will subsequently host a conference call at 4:30 p.m. ET on Wednesday, August 13, 2025 to review financial results and provide an update on corporate developments. Following management's formal remarks, there will be a question-and-answer session. To listen to the conference call, i

HORSHAM, Pa., May 14, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended March 31, 2025, and provides a corporate update. First Quarter 2025 Financial Highlights Revenue in the first quarter of 2025 was $6.8 million, up 1% Global net recurring XTRAC® revenue in the first quarter was $4.5 million vs. $4.6 million in the prior year period, with international growth of 27% offsetting a 4% decline in the domestic marketAverage net revenue per dome

HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2025 financial results on Wednesday, May 14, 2025 after the market close. STRATA management will subsequently host a conference call at 5:00 p.m. ET on Wednesday, May 14, 2025 to review financial results and provide an update on corporate developments. Following management's formal remarks, there will be a question-and-answer session. To listen to the conference call, interested pa

HORSHAM, Pa., March 21, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report fourth quarter and year end 2024 financial results on Thursday, March 27, 2025 after the market close. STRATA management will host a conference call at 4:30 p.m. ET on Thursday, March 27, 2025 to review financial results and provide an update on corporate developments. Following management's formal remarks, there will be a question-and-answer session. To listen to the conference call, interest

HORSHAM, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report third quarter 2024 financial results on Wednesday, November 13, 2024 after the market close. STRATA management will host a conference call at 4:30 p.m. ET on Wednesday, November 13, 2024 to review financial results and provide an update on corporate developments. Following management's formal remarks, there will be a question-and-answer session. To listen to the conference call, interested part

HORSHAM, Pa., Aug. 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report second quarter 2024 financial results on Wednesday, August 14, 2024 after the market close. STRATA management will host a conference call at 4:30 p.m. ET on Wednesday, August 14, 2024 to review financial results and provide an update on corporate developments. Following management's formal remarks, there will be a question-and-answer session. To listen to the conference call, interested parties

HORSHAM, Penn., May 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended March 31, 2024 and provides a corporate update. First Quarter 2024 Highlights Revenue in the first quarter of 2024 was $6.8 million (-11% YOY) vs. $7.6 million in the first quarter of 2023 Global net recurring revenue in the first quarter of 2024 was $4.7 million (-10% YOY) vs. $5.2 million in the first quarter of 2023, and was negatively impacted by deferred billingsGr

HORSHAM, Penn., May 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2024 financial results on Wednesday, May 15, 2024 after the market close. STRATA management will host a conference call at 4:30 p.m. ET on Wednesday, May 15, 2024 to review financial results and provide an update on corporate developments. Following management's formal remarks, there will be a question-and-answer session. To listen to the conference call, interested parties withi

HORSHAM, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) ("STRATA" or "the Company"), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the fourth quarter and full-year ended December 31, 2023. Fourth Quarter and Full-Year 2023 and Recent Business Highlights: Revenue in the fourth quarter of 2023 was $8.7 million Global recurring revenue was $5.6 millionGross domestic recurring billings were $5.3 million Revenue for the full-year 2023 was $33.4 million Global recurring revenue was $21.5 millionGross domestic recurring b

HORSHAM, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it plans to release its fourth quarter and full-year 2023 financial results on Wednesday, March 27, 2024. Management will hold a conference call to review the financial results and provide a corporate update at 4:30 PM ET on the same day. Wednesday, March 27, 2024, 4:30 PM ETDomestic: 877-269-7756International: 201-689-7817Conference ID: 13744189Webcast: STRATA Skin Sciences Earnings Webcast After the li

HORSHAM, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the third quarter ended September 30, 2023. Third Quarter 2023 and Recent Business Highlights: Total Revenues were $8.9 million compared to $9.4 million for the third quarter of 2022, a total decrease of 6.0%.Non-GAAP EBITDA improved to $1.0 million compared to $0.6 million for the third quarter of 2022.Dr. Dolev Rafaeli, named new Vice-Chairman, President and CEO, effective October 31, 2023. "I am pleased to have

HORSHAM, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it plans to release its third quarter 2023 financial results on Tuesday, November 14, 2023. Management will hold a conference call to review the financial results and provide a corporate update at 4:30 PM ET on the same day. Tuesday, November 14, 2023, 4:30 PM ET Domestic: 877-269-7756 International: 201-689-7817 Conference ID: 13741439 Webcast: STRATA Skin Sciences Earnings Webcast After the live webcast, the event will be archived

HORSHAM, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the second quarter ended June 30, 2023. Second Quarter 2023 and Recent Business Highlights: Revenues in the second quarter of 2023 were $8.3 million, compared to $9.1 million for the second quarter of 2022.Secured up to an additional $12 million financing with MidCap Financial.Placed 73 TheraClear®X devices as of June 30, 2023. "Throughout the second quarter, we achieved significant operational milestones, includ

HORSHAM, Pa., July 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second quarter 2023 financial results on Wednesday, August 9, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 PM ET on the same day. Wednesday, August 9, 2023, 4:30 PM ETDomestic: 877-269-7756International: 201-689-7817Conference ID: 13739272Webcast: STRATA Skin Sciences Earnings Webcast After the live webcast, the event will be arc

Achieved revenue of $7.6 million for the first quarter 2023 Company to host conference call and webcast today, May 15, 2023, at 4:30 PM ET HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the first quarter ended March 31, 2023. First Quarter 2023 and Recent Business Highlights: Revenue in the first quarter of 2023 was $7.6, compared to $7.0 million for the first quarter of 2022Officially launched TheraClear®X device in January 202358 TheraClearX devices in the

HORSHAM, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its first quarter 2023 financial results on Monday, May 15, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 PM ET on the same day. Monday, May 15, 2023, 4:30 PM ETDomestic: 877-269-7756International: 201-689-7817Conference ID: 13738266Webcast: STRATA Skin Sciences Earnings Webcast After the live webcast, the event will be archived for fu

Achieved record revenue of $36.2 million, representing 21% increase over the year 2021 Company to host conference call and webcast today, March 31, 2023, at 8:30 AM ET HORSHAM, Pa., March 31, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 and Recent Business Highlights: Revenue in the fourth quarter of 2022 was a record $10.6 million, an increase of 17% over the fourth quarter of 2021 Global recurring rev

HORSHAM, Pa., March 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it will release its fourth quarter 2022 financial results along with its Form 10-K on Friday, March 31, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 8:30 AM EDT on the same day. Friday, March 31, 2023, 8:30 AM EDTDomestic: 877-269-7756International: 201-689-7817Conference ID: 13736453Webcast: STRATA Skin Sciences Earnings Webcast After the live webcast, the even

HORSHAM, Pa., March 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth quarter 2022 financial results on Tuesday, March 28, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 PM EDT on the same day. Tuesday, March 28, 2023, 4:30 PM EDTDomestic: 877-269-7756International: 201-689-7817Conference ID: 13736453Webcast: STRATA Skin Sciences Earnings Webcast After the live webcast, the event will be arch

Strong revenue in the third quarter 2022 of $9.4 million, a 22% increase over the third quarter of 2021Strong international sales of $3.3 million, an 82% increase over the third quarter of 2021Announced U.S. commercial launch of TheraClear®X acne therapy systemCompany to host conference call and webcast today, November 9, 2022 at 4:30 PM EST HORSHAM, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced strong financial results for the third quarter ended September 30, 2022. "We are encouraged by o

HORSHAM, Pa., Oct. 26, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its third quarter 2022 financial results on Wednesday, November 9, 2022. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 PM EST on the same day. Wednesday, November 9, 2022, 4:30 PM ESTDomestic: 877-269-7756International: 201-689-7817Conference ID: 13733102Webcast: STRATA Skin Sciences Earnings Webcast After the live webcast, the event will b

HORSHAM, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the second quarter ended June 30, 2022. Recent Highlights Revenue in the second quarter 2022 of $9.1 million a 23% increase over the second quarter of 2021Cash and cash equivalents at June 30, 2022 were $10.0 millionDomestic installed base increased to 915 XTRAC devicesEntered the estimated $5.5 billion acne care market with initial commercial launch of TheraClear®X, an FDA-cleared device for in-office treatment of

HORSHAM, Pa., July 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second quarter 2022 financial results on Wednesday, August 10, 2022. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the STRATA Skin Sciences website at: www.strataskinsciences.com under the investor relations s

HORSHAM, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the first quarter ended March 31, 2022. Recent Highlights Revenue in the first quarter 2022 of $7.0, a 21% increase over the first quarter of 2021Cash, cash equivalents and restricted cash at March 31, 2022 were $10.9 millionDomestic installed base increased to 903 XTRAC devices at March 31, 2022Became corporate sponsor of the Global Vitiligo FoundationAcquired the rights to Theraclear Acne Treatment System from The

HORSHAM, Pa., April 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its first quarter 2022 financial results on Wednesday, May 11, 2022. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the STRATA Skin Sciences website at: www.strataskinsciences.com under the investor relations sect

HORSHAM, Pa., March 21, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the fourth quarter and full year ended December 31, 2021. Recent Highlights Revenue in the fourth quarter of 2021 was a record $9.1 million, an increase of 35% over the fourth quarter of 2020 Global recurring revenue was $6.7 million, a 32% increase over the fourth quarter of 2020Gross domestic recurring billings were $6.1 million, a 14% increase over the fourth quarter 2020 (See Reconciliation of Non-GAAP measure

HORSHAM, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth quarter and full year 2021 financial results on Monday, March 21, 2022. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the STRATA Skin Sciences website at: www.strataskinsciences.com under the investor

HORSHAM, Pa., Nov. 10, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended September 30, 2021. Third Quarter 2021 Highlights Total revenue was $7.7 million, an increase of 37.4% as compared to the third quarter of 2020 Recurring revenue was $5.7 million, a 48.9% increase over the third quarter of 2020Gross domestic recurring billings were $5.8 million, a 23.5% increase over the third quarter 2020 (See Reconciliation of Non-GAAP measures below) Total gross margins were

HORSHAM, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) ("STRATA" or the "Company"), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its third quarter 2021 financial results after the market closes on Wednesday, November 10, 2021. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the STRATA Skin

HORSHAM, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended June 30, 2021. Recent Highlights Total revenue for the second quarter of 2021 was $7.4 million, an increase of 83.1% as compared to the second quarter of 2020 Recurring revenue for the second quarter of 2021 was $5.5 million, a 95.0% increase over the second quarter of 2020Gross domestic recurring billings were $5.5 million, a 196.6% increase over the second quarter 2020 (See Reconciliation of N

HORSHAM, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) ("STRATA" or the "Company"), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second quarter 2021 financial results after the market closes on Monday, August 16, 2021. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the STRATA Skin Sci